Table 5:
Clinical profile of patients before and after the addition of TAC therapy.
| Urinary protein, mg/kg/day | Number of erythrocytes/μL | eGFR, mL/min/1.73 m2 | Prednisone, mg/day | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. | Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | Treatment effect | Time required for remission months | Number of relapses, n |
| 1 | 17.4 | 2.7 | 6 | 0 | N | N | 10 | 0 | PR | 3 | 0 |
| 2 | 11.0 | 2.0 | 534 | 40 | N | N | 2.5 | 1.25 | CR | 1 | 0 |
| 3 | 7.2 | 0.3 | 0 | 0 | N | N | 7.5 | 0 | CR | 1 | 1 |
| 4 | 16.2 | 33.6 | 5 | 87 | N | N | 15 | 0 | NR | 18 | 1 |
| 5 | 19.1 | 0.5 | 10 | 0 | N | N | 10 | 6.25 | CR | 1 | 0 |
| 6 | 11.6 | 13.2 | 19 | 5 | N | N | 5 | 5 | NR | 1 | 1 |
| 7 | 19.2 | 2.1 | 44 | 6 | N | N | 7.5 | 5 | CR | 1 | 1 |
| 8 | 9.8 | 2.0 | 0 | 0 | N | N | 7.5 | 5 | PR | 24 | 0 |
| 9 | 25.1 | 64.7 | 0 | 344 | N | N | 10 | 5 | NR | 1 | 1 |
| 10 | 32.8 | 14.0 | 78 | 20 | N | N | 2.5 | 1.25 | PR | 3 | 0 |
| 11 | 29.3 | 1.5 | 102 | 149 | N | N | 15 | 12.5 | CR | 1 | 0 |
| 12 | 44.8 | 3.0 | 281 | 231 | N | N | 40 | 2.5 | PR | 1 | 0 |
| 13 | 8.3 | 13.6 | 159 | 222 | N | N | 10 | 7.5 | NR | – | – |
| 14 | 22.2 | 4.1 | 246 | 7 | N | N | 17.5 | 5 | CR | 1 | 0 |
| 15 | 62.4 | 30.9 | 153 | 75 | N | 4.2 | 5 | 2.5 | NR | – | – |
| 16 | 168.4 | 6.7 | 4075 | 39 | N | 88.7 | 25 | 5 | PR | 3 | 0 |
N, normal; CR, complete remission; PR, partial remission; NR, no response.